Human Tenascin C quantitates human Tenascin C in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Tenascin C.
Accession number
150-225 ; AI528729 ; C130033P17Rik ; cytotactine ; surdité, dominante autosomique 56 ; DFNA56 ; antigène de matrice extracellulaire associée au gliome ; GMEM ; GP ; GP 150-225 ; hexabrachion ; hexabrachion (ténascine) ; HXB ; JI ; MGC144208 ; MGC144209 ; MGC167029 ; antigène myotendineux ; neuronéctine ; Ten ; ténascine ; ténascine C ; ténascine C ; domaine supplémentaire de ténascine C 1 ; isoforme de ténascine C 14/AD1/16 ; TN ; Tnc ; TN-C
Dose range
6.1 to 1.500 pg/ml
Sensitivity of the dosage
6.1 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human Tenascin C quantitates human Tenascin C in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Tenascin C.
Human Tenascin C quantitates human Tenascin C in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Tenascin C.
Tenascin is a multifunctional extracellular matrix glycoprotein of high molecular weight expressed in association with epithelio-mesenchymatous interactions during development and neovascularization and stroma of nondifferentiated tumours (Erickson and Bourdon 1989). It has been described under various names: cytotactin, hexabrachion protein, J1, myotendinous antigen (MI) and glioma mesenchymatous extracellular matrix (GMEM). The tenascin molecule is a disulfide-bound hexamer. Tenascin expression is associated with development and growth, both normal and pathological, while distribution in normal adult tissues is restricted.